By Dr Mark Alastair Boyd

Journal articles

Boyd MA, 2009, 'Improvements in antiretroviral therapy outcomes over calendar time', Current opinion in HIV & AIDS, 4, pp. 194 - 199, http://dx.doi.org/10.1097/COH.013e328329fc8d

Colebunders R; French M; Oelrichs R; Boyd M, 2008, 'Editorial introductions', Current Opinion in HIV and AIDS, 3, http://dx.doi.org/10.1097/COH.0b013e32830890a4

Oelrichs R; Boyd M, 2008, 'Evidence and policy in the globalized response to AIDS', Current Opinion in HIV and AIDS, 3, pp. 477 - 480, http://dx.doi.org/10.1097/COH.0b013e328303ba0b

Boyd MA; Truman M; Holes G; Anderson JA; Dwyer DE; Carr AD, 2008, 'A randomized study to evaluate injection site reactions using three different enfuvirtide delivery mechanisms (the OPTIONS study)', Antiviral Therapy, 13, pp. 449 - 453

Boyd MA; Byakwaga H, 2008, 'Considering the benefits of disease-specific interventions on overall public health', Lancet Infectious Diseases, 8, pp. 278 - 278

Boyd MA; Pett SL, 2008, 'Experimental and clinical pharmacology - HIV fusion inhibitors: a review', Australian Prescriber, 31, pp. 66 - 69

Mackowiak PA; Boyd MA; Menon P; Graves S; Gordon DL, 2007, 'A Febrile Illness with Generalized Papular Rash Involving the Palms and Soles', Clinical Infectious Diseases, 44, pp. 755 - 756, http://dx.doi.org/10.1086/511651

Boyd MA; Menon P; Graves S; Gordon DL, 2007, 'A febrile illness with generalized papular rash involving the palms and soles', Clinical Infectious Diseases, 44, http://dx.doi.org/10.1086/511637

Boyd MA; Hedger S, 2007, 'An unusual cause of severe metabolic acidosis [5]', Medical Journal of Australia, 186, pp. 158, http://dx.doi.org/10.5694/j.1326-5377.2007.tb00846.x

Snelling T; Ossowicz C; Boyd M, 2007, 'Case report: Co-infections in an HIV-infected man from Malawi', American Journal of Tropical Medicine and Hygiene, 76, pp. 180 - 181, http://dx.doi.org/10.4269/ajtmh.2007.76.180

Boyd MA; Truman M; Hales GP; Anderson JS; Dwyer DE; Carr AD, 2007, 'A randomized study to evaluate injection site reactions (ISR) using three different mechanisms for delivery of enfuvirtide (ENF): a 27-gauge needle, a 31-gauge needle and a needle-free device', Antiviral Therapy, 12, pp. L57 - L57

Kerr SJ; Duncombe CJ; Avihingsanon A; Ananworanich J; Boyd MA; Sopa B; Chuenyam T; Cooper DA; Lange JM; Phanuphak P; Ruxrungtham K, 2007, 'Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.', Journal of the International Association of Physicians in AIDS Care, 6, pp. 36 - 46

Boyd MA, 2007, 'Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?', Expert Opinion on Pharmacotherapy, 8, pp. 957 - 964

Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG, 2007, 'Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment', HIV Medicine, 8, pp. 46 - 54

Autar R; Boyd MA; Wit F; Ruxrungtham K; Sankote J; Lange JM; Cooper DA; Phanuphak P; Burger DM; Reiss P, 2007, 'Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen', Antiviral Therapy, 12, pp. 1265 - 1271

Boyd MA; Cooper DA, 2007, 'Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research', AIDS, 21, pp. S55 - S63

Cooper DA; Cahn PE; Lewin S; Kaldor JM; McClure C; Kort R; Boyd MA, 2007, 'The Sydney Declaration: a call to scale up research', Lancet, 370, pp. 7 - 8

Boyd M; Clezy K; Lindley R; Pearce R, 2006, 'Pandemic influenza: Clinical issues', Medical Journal of Australia, 185, http://dx.doi.org/10.5694/j.1326-5377.2006.tb00706.x

Kong A; Koukourou A; Boyd M; Crowe G, 2006, 'Metastatic adenocarcinoma mimicking 'target sign' of cerebral tuberculosis', Journal of Clinical Neuroscience, 13, pp. 955 - 958, http://dx.doi.org/10.1016/j.jocn.2005.11.039

Boyd M; Reiss P, 2006, 'Erratum: The long-term effects of antiretroviral therapy: A review (Journal of HIV Therapy 11, 2 (28))', Journal of HIV Therapy, 11

Boyd M; Rogers W, 2006, 'Industry and bioethics: What price the relationship? [3]', PLoS Medicine, 3, pp. 0933, http://dx.doi.org/10.1371/journal.pmed.0030281

Boyd M; Reiss P, 2006, 'The long-term consequences of antiretroviral therapy: A review', Journal of HIV Therapy, 11, pp. 26 - 35

Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange JM; Cooper DA; Phanuphak P, 2006, 'Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).', Antiviral Therapy, 11, pp. 223 - 232

Boyd MA; Carr AD; Ruxrungtham K; Srasuebkul P; Bien D; Law MG; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange J; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to Ritonavir-boosted Indinavir and Efavirenz', Journal of Infectious Diseases, 194, pp. 642 - 650

Boyd MA; Burger D; Phanuphak P; Cooper DA, 2006, 'Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis', AIDS, 20, pp. 1083 - 1085

Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie P; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO, 2006, 'Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir', Pharmacogenetics and Genomics, 16, pp. 321 - 329

Boyd MA; Siangphoe U; Ruxrungtham K; Reiss P; Mahanontharit A; Lange JM; Phanuphak P; Cooper DA; Burger D, 2006, 'The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity', Journal of Antimicrobial Chemotherapy, 57, pp. 1161 - 1167

Boyd MA; Dixit N; Siangphoe U; Buss N; Salgo M; Lange J; Phanuphak P; Cooper DA; Perelson A; Ruxrungtham K, 2006, 'Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: A randomized, controlled trial (HIV-NAT 012)', Journal of Infectious Diseases, 194, pp. 1319 - 1322

Boyd MA; Siangphoe U; Ruxrungtham K; Duncombe CJ; Stek M; Lange JM; Cooper DA; Phanuphak P, 2005, 'Indinavir/ritonavir 800/100mg bid and efavirenz 600mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009', HIV Medicine, 6, pp. 410 - 420

Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Ganning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray JM; Gerlach W; Sun L; Penny R; Symonds GP; Carr AD; Cooper DA, 2005, 'Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients', Journal of Gene Medicine, 7, pp. 552 - 564

Boyd MA; Mootsikapun P; Burger D; Chuenyam T; Ubolyam S; Mahanontharit A; Sangkote J; Bunyaprawit P; Horsakulchai M; Lange JM; Cooper DA; Phanuphak P; Ruxrungtham K, 2005, 'Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients', Antiviral Therapy, 10, pp. 301 - 307

Ananworanich J; Cheunyam T; Teeratakulpisarn S; Boyd MA; Ruxrungtham K; Lange PJ; Cooper PD; Phanuphak PP, 2004, 'Creation of a drug fund for post-clinical trial access to antiretrovirals', Lancet, 364, pp. 101 - 102, http://dx.doi.org/10.1016/S0140-6736(04)16596-3

Law WP; Duncombe CJ; Mahanontharit A; Boyd MA; Ruxrungtham K; Lange JM; Phanuphak P; Cooper DA; Dore GJ, 2004, 'Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort', AIDS, 18, pp. 1169 - 1177

Ruxrungtham K; Boyd MA; Bellibas S; Zhang X; Dorr A; Kolis S; Kinchelow T; Buss N; Patel IH, 2004, 'Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients', Journal of Clinical Pharmacology, 44, pp. 793 - 802

Boyd MA; Zhang X; Dorr A; Ruxrungtham K; Kolis S; Nieforth K; Kinchelow T; Buss N; Patel IH, 2003, 'Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtide', Journal of Clinical Pharmacology, 43, pp. 1382 - 1391

Burger D; Boyd M; Duncombe CJ; Felderhof M; Mahanontharit A; Ruxrungtham K; Ubolyam S; Stek M; Cooper DA; Lange JM; Phanuphak P; Reiss P, 2003, 'Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients', Journal of Antimicrobial Chemotherapy, 51, pp. 1231 - 1238

Boyd MA; Aarnoutse RE; Ruxrungtham K; Stek M; van Heeswijk RP; Lange JM; Cooper DA; Phanuphak P; Burger DM, 2003, 'Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects', Journal of Acquired Immune Deficiency Syndrome, 34, pp. 134 - 139

Law WP; Dore GJ; Duncombe CJ; Mahanontharit A; Boyd MA; Ruxrungtham K; Lange JM; Phanuphak P; Cooper DA, 2003, 'Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001', AIDS, 17, pp. 2191 - 2199

Conference Papers

Lau A; Kong F; Fairley C; Templeton D; Amin J; Phillips S; Law M; Chen M; Bradshaw C; Donovan B; McNulty A; Boyd M; Timms P; Chow E; Regan D; Khaw C; Lewis D; Kaldor J; Ratnayake M; Carvalho N; Hocking J, 2021, 'O11.2 Treatment efficacy of 1g azithromycin versus 100mg doxycycline bi-daily for seven days for asymptomatic rectal Chlamydia trachomatis', in STI treatment, BMJ Publishing Group Ltd, pp. A40.2 - A40, presented at Abstracts for the STI & HIV World Congress, July 14–17 2021, http://dx.doi.org/10.1136/sextrans-2021-sti.111

Gartner C; Boyd M; Bonevski B; Gilks C; Borland R; Courtney R; Cobiac L; McRobbie H; Baker P; Mueller J, 2018, 'CESSATION AND RELAPSE PREVENTION TRIAL: VAPORISED NICOTINE PRODUCTS FOR PEOPLE ON OPIATE SUBSTITUTION THERAPY, OR WHO ARE LIVING WITH HEPATITIS C OR HIV', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S6 - S6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Khaw C; Raw L; Zablotska-Manos I; Boyd M, 2018, 'Chemsex: prevalence, characteristics and associated risk profiles of men who have sex with men in South Australia. A cross-sectional cohort study', in HIV MEDICINE, WILEY, pp. S46 - S46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430174700122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Holt SG; Gracey DM; Mudge DW; Irish AB; Sevastos J; Walker RG; Baer RA; Levy MT; Boyd MA, 2014, 'RENAL FUNCTION TESTING IN PATIENTS ON TENOFOVIR ANTIVIRAL THERAPY', in NEPHROLOGY, WILEY-BLACKWELL, pp. 72 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Achhra AC; Boyd M; Law MG; Matthews G; Kelleher AD; Cooper DA, 2013, 'Sequencing antiretroviral therapy to maximize patient safety: could we move away from ritonavir, abacavir, tenofovir and efavirenz (RATE) - agents that concern prescribers and patients? A feasibility study and call for a trial', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, BELGIUM, Brussels, pp. A51 - A51, presented at 15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, BELGIUM, Brussels, 15 October 2013 - 17 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335230200056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chadwick M; Boyd MA; Cathers B, 1997, 'A water quality modelling tutorial using SIMULINK', in MODSIM 1997: International Congress on Modelling and Simulation, University of Tasmania, Hobart, presented at MODSIM 1997: International Congress on Modelling and Simulation, University of Tasmania, Hobart, 08 December 1997 - 11 December 1997

Boyd MA; Cathers B; Chadwick M; Craig E, 1996, 'Developing a set of teaching exercises in ennvironmental engineering modelling', in 8th Australasian Association for Engineering Education Conference and Convention, University of New South Wales, presented at 8th Australasian Association for Engineering Education Conference and Convention, University of New South Wales, 15 December 1996 - 18 December 1996

Preprints

Stretton B; Kovoor JG; Gupta AK; Ovenden C; Litwin P; Maddern GJ; Boyd M, 2022, Making up for Lost Time: Perioperative Direct Oral Anticoagulant Assay Measurements, http://dx.doi.org/10.22541/au.166723035.55498329/v1

Back to profile page